Showing results (161-170 of 639) with videos related to
Sort By:
Pageof 64
The Journal of Rheumatology|June 7, 2007
The association of race and ethnicity with disease expression in male US veterans with rheumatoid arthritisTed R Mikuls, Salahuddin Kazi, Daisha Cipher, et al.The Lancet. Diabetes & Endocrinology|September 29, 2025
Glucocorticoid-induced osteoporosis: novel concepts and clinical implicationsLorenz C Hofbauer, Juliet E Compston, Kenneth G Saag, et al.Journal of Periodontology|May 10, 2024
Associations between periodontitis and serum anti-malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis: A case-control studyJoyce A Lee, Ted R Mikuls, Harlan R Sayles, et al.Research Square|May 20, 2024
Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement activation and inflammation modulatorsConcepcion Sanchez, Anaamika Campeau, Ru Liu-Bryan, et al.Arthritis Care & Research|June 1, 2020
Incidence, Prevalence, and Burden of Gout in the Veterans Health AdministrationLindsay N Helget, Bryant R England, Punyasha Roul, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2015
Impact of Total Knee Arthroplasty as Assessed Using Patient-Reported Pain and Health-Related Quality of Life Indices: Rheumatoid Arthritis Versus OsteoarthritisAnand Dusad, Sofia Pedro, Ted R Mikuls, et al.Scientific Reports|October 19, 2024
Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulatorsConcepcion Sanchez, Anaamika Campeau, Ru Liu-Bryan, et al.Immunogenetics|February 12, 2014
CASPASE-12 and rheumatoid arthritis in African-AmericansLaura Marshall, Mohammad Obaidullah, Trista Fuchs, et al.Arthritis and Rheumatism|September 30, 2008
Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolaseKarin Lundberg, Andrew Kinloch, Benjamin A Fisher, et al.Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2015
Risk of hospitalized infection among rheumatoid arthritis patients concurrently treated with a biologic agent and denosumabJeffrey R Curtis, Fenglong Xie, Huifeng Yun, et al.Pageof 64